Inhixa 2000 IE (20 mg)

Inhixa 2000 IE (20 mg) is a medicine authorised by Swissmedic under authorisation number 67454. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 June 2020 and the authorisation is valid without a time limit. ATC code B01AB05 places the medicine in the group Antithrombotic agents.

Dispensing category B
Authorisation number 67454
ATC B01AB05
Biotechnological medicines

Authorisation data
Authorisation number	67454
Name	Inhixa 2000 IE (20 mg)
Full name	Inhixa 2000 IE (20 mg), Injektionslösung
Authorisation holder	Viatris Pharma GmbH
Medicinal product code	Biotechnological medicines
Dispensing category	B · Prescription only
ATC code	B01AB05
First authorisation	10 June 2020
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Inhixa 2000 IE (20 mg), Injektionslösung	B	10 June 2020
2	Inhixa 4000 IE (40 mg), Injektionslösung	B	10 June 2020
3	Inhixa 6000 IE (60 mg), Injektionslösung	B	10 June 2020
4	Inhixa 8000 IE (80 mg), Injektionslösung	B	10 June 2020
5	Inhixa 10000 IE (100 mg), Injektionslösung	B	10 June 2020
6	Inhixa 12000 IE (120 mg), Injektionslösung	B	10 June 2020
7	Inhixa 15000 IE (150 mg), Injektionslösung	B	10 June 2020

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	2	Fertigspritze(n)	B01AB05	06.03.3.	B
2	10	Fertigspritze(n)	B01AB05	06.03.3.	B
3	50	Fertigspritze(n)	B01AB05	06.03.3.	B
4	2	Fertigspritze(n)	B01AB05	06.03.3.	B
5	10	Fertigspritze(n)	B01AB05	06.03.3.	B
6	50	Fertigspritze(n)	B01AB05	06.03.3.	B
7	2	Fertigspritze(n)	B01AB05	06.03.3.	B
8	10	Fertigspritze(n)	B01AB05	06.03.3.	B
9	50	Fertigspritze(n)	B01AB05	06.03.3.	B
10	2	Fertigspritze(n)	B01AB05	06.03.3.	B
11	10	Fertigspritze(n)	B01AB05	06.03.3.	B
12	50	Fertigspritze(n)	B01AB05	06.03.3.	B
13	2	Fertigspritze(n)	B01AB05	06.03.3.	B
14	10	Fertigspritze(n)	B01AB05	06.03.3.	B
15	50	Fertigspritze(n)	B01AB05	06.03.3.	B
16	2	Fertigspritze(n)	B01AB05	06.03.3.	B
17	10	Fertigspritze(n)	B01AB05	06.03.3.	B
18	2	Fertigspritze(n)	B01AB05	06.03.3.	B
19	10	Fertigspritze(n)	B01AB05	06.03.3.	B

Scroll the table sideways

Medicines in the same ATC group

Clexane 20 mg/0.2 mlAuthorisation number 49456 · Sanofi-Aventis (Suisse) SA · ATC B01AB05B Clexane multiAuthorisation number 54297 · Sanofi-Aventis (Suisse) SA · ATC B01AB05B Hepaxane 2000 IE/UI (20 mg)/0.2 mlAuthorisation number 67702 · EFFIK SA · ATC B01AB05B Inhixa Multi 30000 IE (300 mg)Authorisation number 67455 · Viatris Pharma GmbH · ATC B01AB05B

Other medicines from this authorisation holder

Abirateron Viatris 500 mgAuthorisation number 68890 · ATC L02BX03B AcetocaustinAuthorisation number 45209 · ATC D11AFB AcnatacAuthorisation number 62513 · ATC D10AF51A Aldara 5 %Authorisation number 55070 · ATC D06BB10A Amlodipin Viatris 5 mgAuthorisation number 59261 · ATC C08CA01B Amlodipin/Valsartan Viatris 5 mg/80 mgAuthorisation number 68131 · ATC C09DB01B Apixaban Viatris 2.5 mgAuthorisation number 70071 · ATC B01AF02B Arixtra 2.5 mg/0.5 mlAuthorisation number 55937 · ATC B01AX05B

Frequently asked questions

Is Inhixa 2000 IE (20 mg) authorised in Switzerland?

Yes. Inhixa 2000 IE (20 mg) is authorised by Swissmedic under authorisation number 67454, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Inhixa 2000 IE (20 mg) have?

Inhixa 2000 IE (20 mg) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Inhixa 2000 IE (20 mg)?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.